Flow cytometry and its use in the diagnosis and management of mature lymphoid malignancies

de Tute R M
(2011) Histopathology 58, 90–105
Flow cytometry and its use in the diagnosis and management of mature lymphoid malignancies

[1]  A. Rawstron,et al.  Clinical and diagnostic implications of monoclonal B-cell lymphocytosis. , 2010, Best practice & research. Clinical haematology.

[2]  L. Medeiros,et al.  Flow cytometric immunophenotyping of anaplastic large cell lymphoma. , 2009, Archives of pathology & laboratory medicine.

[3]  J. Plumas,et al.  Efficient characterization of the TCR repertoire in lymph nodes by flow cytometry , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[4]  Miguel Ángel Martínez,et al.  Comparative analysis of immunoglobulin polymerase chain reaction and flow cytometry in fine needle aspiration biopsy differential diagnosis of non‐Hodgkin B‐cell lymphoid malignancies , 2009, Diagnostic cytopathology.

[5]  A. Chiarenza,et al.  CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia. , 2009, Leukemia research.

[6]  Marcos González,et al.  Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. , 2009, Blood.

[7]  Shigeo Nakamura,et al.  Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance. , 2009, Blood.

[8]  J. Dahlstrom,et al.  Staging bone marrow in diffuse large B‐cell lymphoma: the role of ancillary investigations , 2009, Pathology.

[9]  S. Tugulea,et al.  Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics. , 2009, American journal of clinical pathology.

[10]  Anju Thomas,et al.  Flow cytometry can diagnose classical hodgkin lymphoma in lymph nodes with high sensitivity and specificity. , 2009, American journal of clinical pathology.

[11]  P. Ghia,et al.  Monoclonal B lymphocytosis in the general population , 2009, Leukemia & lymphoma.

[12]  A. Órfão,et al.  A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B‐cell chronic lymphoproliferative disorders , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[13]  N. Harris,et al.  Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. , 2008, Blood.

[14]  C. E. Pedreira,et al.  Generation of flow cytometry data files with a potentially infinite number of dimensions , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[15]  S. Richards,et al.  Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. , 2008, The New England journal of medicine.

[16]  K. McGrath,et al.  Multispectral imaging of hematopoietic cells: where flow meets morphology. , 2008, Journal of immunological methods.

[17]  P. Kurtin,et al.  Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients. , 2008, Mayo Clinic proceedings.

[18]  B. Shadbolt,et al.  Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B‐cell lymphoma (DLBCL) – a new perspective , 2008, Histopathology.

[19]  F. Buccisano,et al.  Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia. , 2008, Blood.

[20]  S. Hudnall,et al.  Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia , 2008, Cytometry. Part B, Clinical cytometry.

[21]  M. Kinney,et al.  Cutaneous T-cell and NK-cell lymphomas: the WHO-EORTC classification and the increasing recognition of specialized tumor types. , 2007, American journal of clinical pathology.

[22]  J. Byrd,et al.  International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia , 2007, Leukemia.

[23]  A. Rawstron,et al.  Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens , 2006, Leukemia.

[24]  B. Wood,et al.  9-color and 10-color flow cytometry in the clinical laboratory. , 2006, Archives of pathology & laboratory medicine.

[25]  C. Dunphy.  Gene expression profiling data in lymphoma and leukemia: review of the literature and extrapolation of pertinent clinical applications. , 2006, Archives of pathology & laboratory medicine.

[26]  C. Fegan,et al.  Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  L. Skoog,et al.  Flow cytometric immunophenotyping including Bcl‐2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non‐Hodgkin's lymphoma , 2005, Cytometry. Part B, Clinical cytometry.

[28]  Wei Yang,et al.  Diminished expression of CD19 in B‐cell lymphomas , 2005, Cytometry. Part B, Clinical cytometry.

[29]  S. Kroft.  Monoclones, monotypes, and neoplasia pitfalls in lymphoma diagnosis. , 2004, American journal of clinical pathology.

[30]  S. Kroft.  Monoclones, Monotypes, and NeoplasiaPitfalls in Lymphoma Diagnosis , 2004 .

[31]  S. Perkins,et al.  Analysis of CD10+ hairy cell leukemia. , 2003, American journal of clinical pathology.

[32]  M. Raffeld,et al.  Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene. , 2003, American journal of clinical pathology.

[33]  M. Raffeld,et al.  Minimal Residual Disease Detection in Hairy Cell Leukemia , 2003 .

[34]  Katharine Liu,et al.  Fine-needle aspiration in non-Hodgkin lymphoma: evaluation of cell size by cytomorphology and flow cytometry. , 2002, American journal of clinical pathology.

[35]  E. Matutes,et al.  New additions to antibody panels in the characterisation of chronic lymphoproliferative disorders. , 2002, Journal of clinical pathology.

[36]  S. Kroft,et al.  Assessment of CD10 in the diagnosis of small B-cell lymphomas: a multiparameter flow cytometric study. , 2002, American journal of clinical pathology.

[37]  I. Check,et al.  Immunophenotyping large B-cell lymphomas. Flow cytometric pitfalls and pathologic correlation. , 2001, American journal of clinical pathology.

[38]  C. Dunphy,et al.  Contribution of flow cytometric immunophenotyping to the evaluation of tissues with suspected lymphoma? , 2000, Cytometry.

[39]  W. Hop,et al.  Flow cytometric analysis of the Vbeta repertoire in healthy controls. , 2000, Cytometry.

[40]  L. Sandhaus.  Fine-needle aspiration cytology in the diagnosis of lymphoma. The next step. , 2000, American journal of clinical pathology.

[41]  K. Geisinger,et al.  Diagnosis and subclassification of primary and recurrent lymphoma. The usefulness and limitations of combined fine-needle aspiration cytomorphology and flow cytometry. , 2000, American journal of clinical pathology.

[42]  Mitchell R. Smith,et al.  Utilization of fine‐needle aspiration cytology and flow cytometry in the diagnosis and subclassification of primary and recurrent lymphoma , 1998, Cancer.

[43]  A. Lanzavecchia,et al.  Clonal expansions of Vδ1+ and Vδ2+ cells increase with age and limit the repertoire of human γδ T cells , 1994 .

[44]  C. Milstein,et al.  A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody , 1979, European journal of immunology.

[45]  M. Djokic.  Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenström's macroglobulinemia , 2010 .

[46]  F. Ricci,et al.  ZAP-70, IgVh, and cytogenetics for assessing prognosis in chronic lymphocytic leukemia. , 2010, Cancer biomarkers : section A of Disease markers.

[47]  L. Peterson,et al.  The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndrome. , 2008, American journal of clinical pathology.

[48]  B. Wood,et al.  2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Recommendations for training and education to perform clinical flow cytometry , 2007, Cytometry. Part B, Clinical cytometry.

[49]  J. Lillard,et al.  The ImageStream System: a key step to a new era in imaging. , 2007, Folia histochemica et cytobiologica.

[50]  Bruce Greig,et al.  2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia , 2007, Cytometry. Part B, Clinical cytometry.

[51]  S. Swerdlow,et al.  bcl-2 expression by multicolor flow cytometric analysis assists in the diagnosis of follicular lymphoma in lymph node and bone marrow. , 2003, American journal of clinical pathology.

[52]  S. Swerdlow,et al.  From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. , 2002, Human pathology.

[53]  A. Lanzavecchia,et al.  Clonal expansions of V delta 1+ and V delta 2+ cells increase with age and limit the repertoire of human gamma delta T cells. , 1994, European journal of immunology.

[54]  A. Saven,et al.  Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. , 1993, Blood.

[55]  J. Ritz,et al.  A unique cell surface antigen identifying lymphoid malignancies of B cell origin. , 1981, The Journal of clinical investigation.